Suzhou MedicalSystem Technology Co., Ltd. Class A

Suzhou MedicalSystem Technology Co., Ltd. Class A

SSSE:603990
22.33
CNY
-0.04
(-0.18%)
0.04EPS
559.61P/E
5.90BMarket Cap
Apr 26Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.78
0.97
1.1
1.3
1.09
1.14
1.35
1.23
1.3
1.09
2.02
1.53
1
0.8
Basic EPS, GAAP
0.17
0.21
0.21
0.24
0.21
0.22
0.19
0.14
0.15
0.12
-0.88
-0.92
0.13
0.03
Free Cash Flow per Basic Share
0.06
-0.12
-0.23
0.02
-0.19
0.13
0.04
0.37
-0.02
0.09
-2.99
-0.87
-0.01
- -
Dividend per Share
0.01
0.01
0.03
0.04
0.07
0.08
0.09
0.09
0.06
0.01
0.06
0.09
0.03
0.02
Book Value per Share
0.59
0.8
1.01
1.61
1.74
1.9
2.02
4.39
3.91
4.87
3.58
2.61
2.73
2.76
Tangible Book Value per Share
0.53
0.75
0.97
1.57
1.71
1.87
1.86
4.23
3.66
4.54
3.2
2.14
2.21
2.21
Basic Weighted Avg Shares
184
186
184
185
246
249
248
250
273
280
306
304
301
324
Sales/Revenue/Turnover
143
180
202
241
269
284
333
308
354
306
618
464
301
258
Operating Margin (%)
14.96
11.4
16.12
12.55
23.06
26.34
25.22
25.11
19.24
19.32
-31.05
-26.16
7.5
1.51
Depreciation Expense
2
2
3
6
11
12
14
15
16
17
34
79
31
- -
Net Income, GAAP
31
39
39
45
51
55
47
35
42
34
-269
-279
39
11
Effective Tax Rate (%)
13.39
12.62
14.47
8.18
7.94
8.89
12.62
13.6
15.26
18.52
- -
- -
8.61
18.16
Profit Margin (%)
21.77
21.75
19.3
18.79
19.02
19.52
14.08
11.5
11.86
10.99
-43.59
-60.22
12.99
4.34
Working Capital
85
84
94
245
202
214
224
963
760
1,001
-632
592
454
439
LT Debt
- -
32
85
75
- -
- -
- -
11
9
6
822
199
54
74
Total Equity
108
148
187
395
434
473
507
1,241
1,096
1,360
1,100
805
845
854
Return on Invested Capital (%)
13.19
9.42
8.69
5.18
9.49
10.51
8.12
4.34
3.57
2.84
- -
- -
3.99
1.21
Return on Capital (%)
27.98
23.92
15.2
10.9
10.21
10.97
8.35
3.42
3.59
2.58
- -
- -
4.15
1.66
Return on Common Equity (%)
33.46
30.65
23.31
15.55
12.33
12.25
9.66
4.11
3.61
2.74
-21.97
-29.48
4.79
1.34

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
225
174
161
LT Borrowings
- -
20
40
LT Finance Leases
37
36
34
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
306
305
305
Market Capitalization
4,585
6,499
5,903

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
772
726
684
Cash, Cash Equivalents & STI
538
490
455
Accounts Receivable, Net
176
176
175
Inventories
34
32
35
Total Current Liabilities
329
306
245
Payables & Accruals
- -
- -
- -
ST Debt
225
174
161
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
25.39%
-5.71%
5.05%
Free Cash Flow
-510.05%
-906.61%
-98.8%
Net Income, GAAP
-101.7%
-202.94%
-114.01%
Sales/Revenue/Turnover
8.99%
8.71%
-35.04%
Total Cash Common Dividend
49.22%
55.4%
-61.18%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
111
145
104
104
464
2025
63
72
- -
79
301
2026
62
61
57
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
-0.28
-0.3
-0.37
-0.92
2025
0.08
0.02
- -
0.02
0.13
2026
0.01
0.01
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.04
0.07
-0.05
0.09
2025
0.02
0.01
- -
- -
0.03
2026
- -
- -
- -
- -
- -

Company Description

CEO
Kang Weng
Full Time Employees
632
Sector
Technology services
Industry
Packaged software
Address
No. 222, GuiJiaXiang Suzhou JS China 215021
IPO Date
Dec 8, 2016
Business
Suzhou MedicalSystem Technology Co., Ltd. specializes in clinical medical management information systems and solutions within the digital hospital field in China. The company produces and markets the DoCare series of clinical information system software, which includes anesthesia clinical information systems focused on perioperative clinical work; intensive auxiliary diagnosis systems for ICU patients that analyze treatment, inspection, nursing, and doctors' advice data; operative medical behavior management systems for resource and personnel operation management; emergency clinical information systems covering pre-hospital first aid, triage, rescue, observation, emergency operating rooms, emergency ICUs, and patient outcomes; and pre-hospital first aid clinical platforms integrating emergency command centers, doctors, nurses, and patients. Additionally, it offers smart operating theater (OT), ICU, and emergency solutions, alongside specialty solutions such as laminar airflow rooms, clinical pathways, mobile nursing systems, and central sterile supply department management systems. The company operates primarily in China, serving hospitals and healthcare facilities. Founded in 2005 and headquartered in Suzhou, China, it also operates in segments including assisted reproductive medical services and renewable energy photovoltaic businesses. In recent major developments, Suzhou MedicalSystem Technology completed the divestment of two subsidiaries in early 2025: Mianyang Xinhao New Energy Technology and MedicalSystem Power Technology (Suzhou), reflecting a strategic refocus on core clinical informatics. Earlier in late 2024, it agreed to and approved the sale of MedicalSystem Power Technology (Suzhou) for CNY 37.5 million. The company has also signed agreements to acquire remaining stakes in healthcare entities such as Haikou Mary Hospital, expanding its medical services footprint. Suzhou MedicalSystem continues to collaborate with ecosystem partners on intelligent health and wellness robot solutions, reflecting its digital hospital integration strategy and innovation in clinical informatics platforms.